KR20190070985A - RORc 조절제로서의 피리다진 유도체 - Google Patents
RORc 조절제로서의 피리다진 유도체 Download PDFInfo
- Publication number
- KR20190070985A KR20190070985A KR1020197015558A KR20197015558A KR20190070985A KR 20190070985 A KR20190070985 A KR 20190070985A KR 1020197015558 A KR1020197015558 A KR 1020197015558A KR 20197015558 A KR20197015558 A KR 20197015558A KR 20190070985 A KR20190070985 A KR 20190070985A
- Authority
- KR
- South Korea
- Prior art keywords
- undeca
- difluorophenyl
- trien
- dimethyl
- diazatricyclo
- Prior art date
Links
- 0 CCC=[C@@]=C(C=CC(OCC)=*)N=CC(C)=C[Tl] Chemical compound CCC=[C@@]=C(C=CC(OCC)=*)N=CC(C)=C[Tl] 0.000 description 11
- YQOBCBDOFFPRPM-UHFFFAOYSA-N C=C1CC=NC(C=O)=C=CC1 Chemical compound C=C1CC=NC(C=O)=C=CC1 YQOBCBDOFFPRPM-UHFFFAOYSA-N 0.000 description 1
- VWJAZMUQEOTNMZ-OQRWROFFSA-N CC(C)([C@@H](CC1)c2c3nnc(-c(c(F)ccc4)c4F)c2)[C@]13c1nc(-c2ccc(NS(C)(=O)=O)nn2)ccc1 Chemical compound CC(C)([C@@H](CC1)c2c3nnc(-c(c(F)ccc4)c4F)c2)[C@]13c1nc(-c2ccc(NS(C)(=O)=O)nn2)ccc1 VWJAZMUQEOTNMZ-OQRWROFFSA-N 0.000 description 1
- DAJNLNIPKIGOMD-QKVFXAPYSA-N CC(C)([C@@H](CC1)c2c3nnc(-c(c(F)ccc4)c4F)c2)[C@]13c1nc(Cl)ncc1 Chemical compound CC(C)([C@@H](CC1)c2c3nnc(-c(c(F)ccc4)c4F)c2)[C@]13c1nc(Cl)ncc1 DAJNLNIPKIGOMD-QKVFXAPYSA-N 0.000 description 1
- VXKTXWPPZVDJSD-LMKMVOKYSA-N CC(C)([C@@H](CC1)c2cc(-c(c(F)ccc3)c3F)nnc22)[C@]12c1ccnc(N2CCNCC2)n1 Chemical compound CC(C)([C@@H](CC1)c2cc(-c(c(F)ccc3)c3F)nnc22)[C@]12c1ccnc(N2CCNCC2)n1 VXKTXWPPZVDJSD-LMKMVOKYSA-N 0.000 description 1
- ZYDDXJWFRNQQRK-XMHCIUCPSA-N CC(C)([C@@H](CC1)c2cc(-c(c(F)ccc3)c3F)nnc22)[C@]12c1nc(Cl)ccc1 Chemical compound CC(C)([C@@H](CC1)c2cc(-c(c(F)ccc3)c3F)nnc22)[C@]12c1nc(Cl)ccc1 ZYDDXJWFRNQQRK-XMHCIUCPSA-N 0.000 description 1
- SPRFBIYYNSXOLD-PSLXWICFSA-N CC(C)[C@@](CC[C@@H]1C#C)(c2nc(Cl)ncc2)c2c1cc(-c(c(F)ccc1)c1F)nn2 Chemical compound CC(C)[C@@](CC[C@@H]1C#C)(c2nc(Cl)ncc2)c2c1cc(-c(c(F)ccc1)c1F)nn2 SPRFBIYYNSXOLD-PSLXWICFSA-N 0.000 description 1
- SKVNUESGXMAAPB-MQNRADLISA-N CC(C)[C@@](CC[C@H](C)c1c2)(c3nc(-c4n[nH]cc4)ncc3)c1nnc2-c(c(F)ccc1)c1F Chemical compound CC(C)[C@@](CC[C@H](C)c1c2)(c3nc(-c4n[nH]cc4)ncc3)c1nnc2-c(c(F)ccc1)c1F SKVNUESGXMAAPB-MQNRADLISA-N 0.000 description 1
- YYYZOZIQFNXLHU-YZKIHCQESA-N CC(C[C@H]1c2c3nnc(-c(c(F)ccc4)c4F)c2)C1(C(C)C1)[C@@]31c1ccnc(N2CCN(CCS(C)(=O)=O)CC2)n1 Chemical compound CC(C[C@H]1c2c3nnc(-c(c(F)ccc4)c4F)c2)C1(C(C)C1)[C@@]31c1ccnc(N2CCN(CCS(C)(=O)=O)CC2)n1 YYYZOZIQFNXLHU-YZKIHCQESA-N 0.000 description 1
- TVOJIBGZFYMWDT-UHFFFAOYSA-N CC1(C)OB(c2c[nH]nc2)OC1(C)C Chemical compound CC1(C)OB(c2c[nH]nc2)OC1(C)C TVOJIBGZFYMWDT-UHFFFAOYSA-N 0.000 description 1
- CYKFFBFQYWLUJP-UHFFFAOYSA-N CCOC(C=[O](CC)(c1ccccc1)c1ccccc1)=O Chemical compound CCOC(C=[O](CC)(c1ccccc1)c1ccccc1)=O CYKFFBFQYWLUJP-UHFFFAOYSA-N 0.000 description 1
- FXTDHDQFLZNYKW-UHFFFAOYSA-N Nc(nn1)ccc1Br Chemical compound Nc(nn1)ccc1Br FXTDHDQFLZNYKW-UHFFFAOYSA-N 0.000 description 1
- ISJXNXLEMZFCKD-UHFFFAOYSA-N OC1(COC1)c1n[nH]cn1 Chemical compound OC1(COC1)c1n[nH]cn1 ISJXNXLEMZFCKD-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/50—Pyridazines; Hydrogenated pyridazines
- A61K31/502—Pyridazines; Hydrogenated pyridazines ortho- or peri-condensed with carbocyclic ring systems, e.g. cinnoline, phthalazine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Physical Education & Sports Medicine (AREA)
- Pulmonology (AREA)
- Epidemiology (AREA)
- Rheumatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Dermatology (AREA)
- Pain & Pain Management (AREA)
- Neurology (AREA)
- Urology & Nephrology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Plural Heterocyclic Compounds (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662415905P | 2016-11-01 | 2016-11-01 | |
| US62/415,905 | 2016-11-01 | ||
| PCT/EP2017/077931 WO2018083105A1 (fr) | 2016-11-01 | 2017-10-31 | Dérivés de pyridazine utilisés en tant que modulateurs de rorc |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| KR20190070985A true KR20190070985A (ko) | 2019-06-21 |
Family
ID=60201586
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| KR1020197015558A KR20190070985A (ko) | 2016-11-01 | 2017-10-31 | RORc 조절제로서의 피리다진 유도체 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US11008312B2 (fr) |
| EP (1) | EP3535255A1 (fr) |
| JP (1) | JP2019533000A (fr) |
| KR (1) | KR20190070985A (fr) |
| CN (1) | CN110225907A (fr) |
| BR (1) | BR112019008821A8 (fr) |
| CA (1) | CA3042317A1 (fr) |
| MX (1) | MX2019005090A (fr) |
| RU (1) | RU2757571C2 (fr) |
| WO (1) | WO2018083105A1 (fr) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MA55138A (fr) * | 2018-11-19 | 2021-09-29 | Ifm Due Inc | Composés et compositions pour traiter des états pathologiques associés à une activité de sting |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20060173183A1 (en) * | 2004-12-31 | 2006-08-03 | Alantos Pharmaceuticals, Inc., | Multicyclic bis-amide MMP inhibitors |
| EP1904455B1 (fr) * | 2005-07-05 | 2011-08-17 | F. Hoffmann-La Roche AG | Derives de pyridazine |
| PL2599774T3 (pl) * | 2010-07-29 | 2017-01-31 | Astellas Pharma Inc. | Skondensowane związki pirydynowe, jako ligandy receptorów kannabinoidowych cb2 |
| CA2929194A1 (fr) * | 2013-11-05 | 2015-05-14 | F. Hoffmann-La Roche Ag | Derives de 5,6,7,8-tetrahydro-5,8-methanocinnoline a titre de modulateurs rorc pour le traitement des maladies auto-immunes |
| CN105916852B (zh) * | 2014-01-10 | 2020-04-24 | 豪夫迈·罗氏有限公司 | 作为RORc调节剂的芳基磺内酰胺衍生物 |
| EP3292111A1 (fr) * | 2015-05-04 | 2018-03-14 | H. Hoffnabb-La Roche Ag | DÉRIVÉS DE PYRIDAZINE EN TANT QUE MODULATEURS DE RORc |
-
2017
- 2017-10-31 KR KR1020197015558A patent/KR20190070985A/ko active IP Right Grant
- 2017-10-31 JP JP2019523757A patent/JP2019533000A/ja active Pending
- 2017-10-31 CN CN201780081898.1A patent/CN110225907A/zh active Pending
- 2017-10-31 RU RU2019115791A patent/RU2757571C2/ru active
- 2017-10-31 BR BR112019008821A patent/BR112019008821A8/pt not_active Application Discontinuation
- 2017-10-31 WO PCT/EP2017/077931 patent/WO2018083105A1/fr unknown
- 2017-10-31 EP EP17792068.3A patent/EP3535255A1/fr not_active Withdrawn
- 2017-10-31 MX MX2019005090A patent/MX2019005090A/es unknown
- 2017-10-31 CA CA3042317A patent/CA3042317A1/fr active Pending
-
2019
- 2019-04-30 US US16/398,795 patent/US11008312B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| RU2019115791A3 (fr) | 2020-12-17 |
| WO2018083105A1 (fr) | 2018-05-11 |
| JP2019533000A (ja) | 2019-11-14 |
| BR112019008821A8 (pt) | 2020-02-04 |
| RU2019115791A (ru) | 2020-12-03 |
| EP3535255A1 (fr) | 2019-09-11 |
| CN110225907A (zh) | 2019-09-10 |
| US11008312B2 (en) | 2021-05-18 |
| RU2757571C2 (ru) | 2021-10-18 |
| US20190263794A1 (en) | 2019-08-29 |
| MX2019005090A (es) | 2019-09-02 |
| CA3042317A1 (fr) | 2018-05-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP4076662B1 (fr) | Dérivés de pyrazolyle utiles en tant qu'agents anticancéreux | |
| US11780845B2 (en) | FGFR inhibitors and methods of use thereof | |
| JP7058636B2 (ja) | サイクリン依存性キナーゼ７（ｃｄｋ７）の阻害剤 | |
| US10294229B2 (en) | Heteroaryl substituted aminopyridine compounds | |
| EP3313844B1 (fr) | Composés d'aminopyridine à substitution hétéroaryle | |
| RU2638116C2 (ru) | Пиразоло[3,4-с]пиридины и способы их применения | |
| KR101546167B1 (ko) | 브루톤 티로신 키나아제의 억제제 | |
| US8901313B2 (en) | 6,5-heterocyclic propargylic alcohol compounds and uses therefor | |
| JP2018158942A (ja) | Ｔａｎｋ結合キナーゼ阻害剤化合物として有用なアミノトリアジン誘導体 | |
| JP2019519484A (ja) | 芳香族スルホンアミド誘導体 | |
| JP2023544476A (ja) | Ｌｐａ受容体アンタゴニストとしてのトリアゾール－ピリジニル置換アザシクロヘキシル酢酸化合物 | |
| CA3065309A1 (fr) | Composes contenant de l'azote substitue | |
| JP7266592B2 (ja) | ピリミジンＴＢＫ／ＩＫＫεインヒビター化合物およびそれらの使用 | |
| EP1785418A1 (fr) | Derive de pyrazole | |
| US11008312B2 (en) | Pyridazine derivatives as RORc modulators | |
| IL298188A (en) | Circular structures of piperazine | |
| US10487068B2 (en) | Pyridazine derivatives as RORc modulators | |
| WO2023201185A1 (fr) | Pyrido[3,2-d]pyrimidines utilisés comme inhibiteurs de hpk1 | |
| WO2024054832A1 (fr) | COMPOSÉS DE DÉGRADATION CK1α ET DOUBLE CK1α/GSPT1 | |
| CA3176957A1 (fr) | Derives d'aminopyrimidine et leur utilisation en tant que modulateurs du recepteur d'hydrocarbure aryle | |
| KR20240068583A (ko) | Lpa 수용체 길항제로서의 트리아졸-피리디닐 치환된 아자시클로헥실 아세트산 화합물 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| E902 | Notification of reason for refusal | ||
| E701 | Decision to grant or registration of patent right |